BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  BioClinica, Inc. Responds to Shareholder Letter

  October 1, 2010

   · 

  1 min read
• Policy

  Merck & Co., Inc. to Appeal Verdict in Massachusetts Medicaid Case

  October 1, 2010

   · 

  1 min read
• Alcon, Inc. Independent Director Committee Stands Firm in Commitment to Minority Shareholders

  October 1, 2010

   · 

  1 min read
• Business

  Merck & Co., Inc. to Hold Third-Quarter 2010 Sales and Earnings Conference Call on Oct. 29

  October 1, 2010

   · 

  1 min read
• Business

  Cortex Pharmaceuticals, Inc. Regains Rights to Develop Its AMPAKINE Compounds to Treat Depression and Schizophrenia

  October 1, 2010

   · 

  3 min read
• Embera NeuroTherapeutics, Inc.’ Lead Candidate, EMB-001, Supported by $3.9M Grant from National Institute on Drug Abuse

  October 1, 2010

   · 

  2 min read
• BioMimetic Therapeutics, Inc. to Present at the 2010 William Blair Emerging Growth Stock Conference

  October 1, 2010

   · 

  1 min read
• DMARDs, Glucocorticoids, Biologics Similar for Rheumatoid Arthritis

  October 1, 2010

   · 

  1 min read
• HbA1c Not a Sure-Fire Tool for Diabetes Dx

  October 1, 2010

   · 

  1 min read
• Number of Shares in Elekta

  October 1, 2010

   · 

  1 min read